VIVUS Inc. (VVUS)

3.40
NASDAQ : Health Technology
Prev Close 3.39
Day Low/High 3.34 / 3.41
52 Wk Low/High 2.15 / 7.75
Avg Volume 38.70K
Exchange NASDAQ
Shares Outstanding 10.64M
Market Cap 36.06M
EPS -3.50
P/E Ratio N/A
Div & Yield N.A. (N.A)
June 6th Options Now Available For Vivus (VVUS)

June 6th Options Now Available For Vivus (VVUS)

Investors in Vivus, Inc. saw new options become available today, for the June 6th expiration.

Why Vivus (VVUS) Stock Is Up Today

Why Vivus (VVUS) Stock Is Up Today

Vivus (VVUS) rose Wednesday after Aspen Investment Fund said it is considering acquiring the pharmaceutical company for $640 million.

A Greek Lawyer Managing a Little-Known Investment Fund Wants to Buy Vivus for $640 Million

A Greek Lawyer Managing a Little-Known Investment Fund Wants to Buy Vivus for $640 Million

Aspen Investments and Zoi Potsi, a resident of Cyprus, declared a 9.65% ownership stake in struggling obesity pill marketer Vivus this morning and say they want to buy the rest of the company for $640 million.

Interesting VVUS Put And Call Options For August 16th

Interesting VVUS Put And Call Options For August 16th

Investors in Vivus, Inc. saw new options begin trading this week, for the August 16th expiration.

The Stupid and Financially Reckless Argument for Eisai Buying Arena Pharma

The Stupid and Financially Reckless Argument for Eisai Buying Arena Pharma

Japanese companies have a history of paying grossly inflated prices for U.S. assets, but the drug maker Eisai would have to be monumentally stupid -- and financially reckless -- to buy out its obesity drug partner Arena Pharmaceuticals.

Perilous Reversal Stock: Vivus (VVUS)

Perilous Reversal Stock: Vivus (VVUS)

Trade-Ideas LLC identified Vivus (VVUS) as a "perilous reversal" (up big yesterday but down big today) candidate

Why VIVUS (VVUS) Stock is Surging Today

Why VIVUS (VVUS) Stock is Surging Today

VIVUS (VVUS) rose Tuesday after the pharmaceutical company crushed analysts' estimates with its first-quarter report despite a dip in prescriptions of Qsymia, its obesity treatment drug.

3 Stocks Under $10 Making Big Moves

3 Stocks Under $10 Making Big Moves

When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

First Week of December 20th Options Trading For Vivus (VVUS)

First Week of December 20th Options Trading For Vivus (VVUS)

Investors in Vivus, Inc. saw new options begin trading this week, for the December 20th expiration.

Vivus Enters Oversold Territory (VVUS)

Vivus Enters Oversold Territory (VVUS)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Why Vivus (VVUS) Stock Is Plunging Today

Why Vivus (VVUS) Stock Is Plunging Today

Shares of Vivus (VVUS) are down 7.12% to $5.74 after Piper Jaffray downgraded the stock earlier today to"underweight" from "neutral."

April 4th Options Now Available For Vivus (VVUS)

April 4th Options Now Available For Vivus (VVUS)

Investors in Vivus, Inc. saw new options begin trading today, for the April 4th expiration.

Insider Trading Alert - HLX, NLSN And VVUS Traded By Insiders

Insider Trading Alert - HLX, NLSN And VVUS Traded By Insiders

Stocks with insider trader activity include HLX, NLSN and VVUS

2 Biotech Stocks Under $10 to Trade

2 Biotech Stocks Under $10 to Trade

Keep these under-$10 biotech stocks on your radar.

VVUS March 7th Options Begin Trading

VVUS March 7th Options Begin Trading

Investors in Vivus, Inc. saw new options become available today, for the March 7th expiration.

Vivus is Now Oversold (VVUS)

Vivus is Now Oversold (VVUS)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Interesting VVUS Put And Call Options For May 17th

Interesting VVUS Put And Call Options For May 17th

Investors in Vivus, Inc. saw new options become available this week, for the May 17th expiration.

Why Vivus (VVUS) Is Down Today

Why Vivus (VVUS) Is Down Today

Vivus (VVUS) falls despite the pharmaceutical company's report of fourth-quarter earnings that beat analysts' expectations. The company reported a net loss of 17 cents a share, which was much narrower than the Zacks consensus estimate of 43 cents and the year-ago loss of 56 cents. Revenue for the fourth quarter increased year-over-year to $44.1 million from $2 million; however, these earnings included a one-time licensing payment of about $34.8 million, or about 34 cents a share, from its erectile dysfunction drug. Vivus beat expectations, but only did so because of the licensing payment. Analysts expected a loss of 40 cents a share and the company would have posted a loss of approximately 51 cents a share were it not for the payment. The company also announced that its anti-obesity drug Qsymia totaled approximately 124,000 for total sales of $7.7 million for the quarter, a 14% sequential increase. Despite this, both JP Morgan (JPM) and JMP Securities noted they do not see Qsymia gaining traction anytime soon. JP Morgan downgraded the company to "hold" from "buy," while JMP Securities reiterated its "market perform" rating.

Interesting VVUS Put And Call Options For February 28th

Interesting VVUS Put And Call Options For February 28th

Investors in Vivus, Inc. saw new options begin trading today, for the February 28th expiration.

VVUS February 14th Options Begin Trading

VVUS February 14th Options Begin Trading

Investors in Vivus, Inc. saw new options begin trading today, for the February 14th expiration.

February 7th Options Now Available For Vivus (VVUS)

February 7th Options Now Available For Vivus (VVUS)

Investors in Vivus, Inc. saw new options become available today, for the February 7th expiration.

Vivus is Now Oversold (VVUS)

Vivus is Now Oversold (VVUS)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Interesting VVUS Put And Call Options For January 31st

Interesting VVUS Put And Call Options For January 31st

Investors in Vivus, Inc. saw new options begin trading today, for the January 31st expiration.

VVUS January 24th Options Begin Trading

VVUS January 24th Options Begin Trading

Investors in Vivus, Inc. saw new options begin trading today, for the January 24th expiration.

VIVUS Collaborates With Aetna To Test First Comprehensive Weight Management Program Integrating Weight Loss Medication

VIVUS Collaborates With Aetna To Test First Comprehensive Weight Management Program Integrating Weight Loss Medication

New Program, Available Now, Integrates Qsymia to Help Bridge the Gap Between Lifestyle Interventions and Surgical Treatments

TheStreet Quant Rating: D (Sell)